These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 17968620
1. Factors limiting complete tumor ablation by radiofrequency ablation. Paulet E, Aubé C, Pessaux P, Lebigot J, Lhermitte E, Oberti F, Ponthieux A, Calès P, Ridereau-Zins C, Pereira PL. Cardiovasc Intervent Radiol; 2008; 31(1):107-15. PubMed ID: 17968620 [Abstract] [Full Text] [Related]
2. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, Iwakiri H, Uto H, Kato J, Ido A, Hayashi K, Tsubouchi H. J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605 [Abstract] [Full Text] [Related]
18. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Solbiati L, Ahmed M, Cova L, Ierace T, Brioschi M, Goldberg SN. Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175 [Abstract] [Full Text] [Related]
19. [Application of contrast-enhanced ultrasonography in selecting indication of radiofrequency ablation among hepatocellular carcinoma patients]. Chen MH, Wu W, Yang W, Gao W, Dai Y, Yin SS, Huo L, Yan K. Zhonghua Yi Xue Za Zhi; 2005 Dec 28; 85(49):3491-4. PubMed ID: 16686066 [Abstract] [Full Text] [Related]